Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cellebrite DI Q1 2024 Adj EPS $0.08 Beats $0.06 Estimate, Sales $89.582M Beat $87.757M Estimate

Author: Benzinga Newsdesk | May 23, 2024 07:03am
Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.06 by 33.33 percent. This is a 166.67 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $89.582 million which beat the analyst consensus estimate of $87.757 million by 2.08 percent. This is a 25.76 percent increase over sales of $71.234 million the same period last year.

Posted In: CLBT